Newron Pharmaceuticals
NWRN.SW
#8299
Rank
HK$1.33 B
Marketcap
HK$69.57
Share price
-0.62%
Change (1 day)
72.30%
Change (1 year)

Revenue for Newron Pharmaceuticals (NWRN.SW)

Revenue in 2023: HK$77.79 Million

According to Newron Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is HK$77.79 Million. In 2023 the company made a revenue of HK$77.79 Million an increase over the revenue in the year 2022 that were of HK$50.79 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Newron Pharmaceuticals from 2005 to 2023

Annual revenue

Year Revenue Change
2023HK$77.79 M53.16%
2022HK$50.79 M0.17%
2021HK$50.7 M0.9%
2020HK$50.25 M-17.97%
2019HK$61.26 M71.22%
2018HK$35.77 M-71.42%
2017HK$0.12 B218.38%
2016HK$39.32 M94.46%
2015HK$20.22 M37.42%
2014HK$14.71 M-61.25%
2013HK$37.97 M-58.6%
2012HK$91.72 M111.93%
2011HK$43.27 M568.93%
2010HK$6.46 M-77.14%
2009HK$28.29 M-33.76%
2008HK$42.72 M-8.02%
2007HK$46.44 M280.38%
2006HK$12.21 M
2005N/A